Beta Blocker News and Research

RSS

Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.

Women receive lower-quality heart attack care than men

A new study shows that a puzzling gap between the sexes persists in hospital care for heart attack patients, despite specific efforts by hospitals to improve the way they treat all patients immediately after a heart attack.

10 Jul 2006

Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients

Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients, according to a study in the July 5 issue of Journal of the American Medical Association.

4 Jul 2006

New guidelines for treating high blood pressure discounts beta-blockers

Drug treatment for high blood pressure is set to undergo a major shake-up after new guidance was issued for the NHS.

28 Jun 2006

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

The combination of drugs traditionally used to control blood pressure might not be ideal for Hispanic patients, University of Florida researchers warn.

23 May 2006

Smokers more likely to receive jolt from defibrillators

If some patients with heart disease don't take their doctor's advice to quit smoking, they are probably going to get "shocking" reminders.

8 May 2006

Hypnotherapy relieves chest pain not linked to heart disease

According to a small study in the UK, hypnotherapy was helpful in relieving the angina-like chest pain experienced by some people which is not caused by heart disease.

23 Apr 2006

Study assesses formularies across Medicare drug plans

Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.

11 Apr 2006

Angina is more dangerous for women than was previously thought

The collaborative study, led by UCL (University College London) and funded by the British Heart Foundation, found that angina in women is as common as it is in men, in contrast to heart attacks (myocardial infarction) which have a higher rate in men.

21 Mar 2006

Study identifies patients at risk for sudden cardiac death

Researchers have found a more accurate way to tell which children and teenagers are likely to be among the thousand or so who suddenly die each year in the United States from genetic heart conditions that cause arrhythmia

21 Mar 2006

GlaxoSmithKline receives NDA for Coreg CR

GlaxoSmithKline has announced that the new drug application (NDA) for Coreg CR has been accepted for review by the U.S. Food and Drug Administration (FDA).

17 Mar 2006

New model is able to accurately predict survival for patients with heart failure

A new model developed at the University of Washington provides an accurate estimate of one-, two-, and three-year survival rates and average years of survival for patients with heart failure.

15 Mar 2006

Taking medications to lower blood pressure may be associated with a lower incidence of Alzheimer's disease

Taking medications to lower blood pressure, particularly those known as diuretics, may be associated with a lower incidence of Alzheimer's disease, according to a study in the May 2006 print issue of Archives of Neurology.

15 Mar 2006

Nebivolol may restore damaged cardiovascular functions in African Americans

Tadeusz Malinski, Marvin & Ann Dilley White Professor of Chemistry and Biochemistry, found that the drug, currently under review by the U.S. Food and Drug Administration, acts on the level of oxidants lining the cardiovascular system and can restore levels of nitric oxide and reduce oxidative stress.

9 Mar 2006

Statins lessen heart attack risk

For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.

24 Feb 2006

Statins and beta blockers may reduce heart attack risk

For patients with undiagnosed heart disease, taking a statin or beta blocker could mean the difference between experiencing mild chest pain, or having a full-blown heart attack as a first symptom. That's the finding of a Kaiser Permanente study in the February 21 issue of the Annals of Internal Medicine.

21 Feb 2006

Almost half of heart attacks are not recognised

According to Dutch researchers almost fifty percent of heart attacks are not recognised as such.

14 Feb 2006

$3.7 million to improve high blood pressure control

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched a $3.7 million, three-year educational effort to improve high blood pressure control nationwide.

5 Feb 2006

Angina drug finally gets the ok

U.S. regulators have granted approval for the drug Ranexa in the treatment of chronic angina.

31 Jan 2006

$Warfarin increases risk of bone fracture$

Warfarin increases risk of bone fracture

Elderly patients taking the commonly prescribed blood thinner warfarin experience an increased risk for osteoporosis-linked bone fractures, according to a study at Washington University School of Medicine in St. Louis.

23 Jan 2006

First-of-its-kind study in heart attack patients seeks to prevent heart failure with stem cells

University of Rochester Medical Center researchers have announced the launch of a study that will examine whether transplanted stem cells can be safely used to treat damaged heart muscle in patients just after their first heart attack.

23 Jan 2006